CervoMed Inc. (CRVO) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Find CervoMed Inc. (CRVO) short-term stock forecasts for 2025 by month and long-term price predictions for 2025 to 2050. View past performance, analyst Buy, Sell or Hold ratings, and the latest CRVO stock news and headlines.
1 Month Prediction
$34.59 [400.51%]
3 Month Prediction
$24.69 [257.27%]
6 Month Prediction
$19.81 [186.71%]
1 Year Prediction
$18.37 [165.77%]
3 Year Prediction
$44.94 [550.42%]
5 Year Prediction
$39.02 [464.68%]
About CervoMed Inc.
CervoMed Inc. is a clinical-stage biotechnology company that develops and commercialized drug treatments for neurodegenerative diseases. The company develops therapies targeting neurodegenerative diseases, including conditions like dementia with Lewy bodies.
CervoMed's primary therapeutic candidate is neflamapimod, an orally administered, brain-penetrant small molecule inhibitor that targets the alpha isoform of p38 MAP kinase. This enzyme is implicated in synaptic dysfunction, a reversible aspect of neurodegenerative processes. Neflamapimod is currently under investigation for the treatment of dementia with Lewy bodies (DLB), Alzheimer's disease, and stroke recovery.
It also performs studies on cancer, stroke, and heart attack through partnerships with cancer centers
The company was founded in 2014, and is headquartered in Boston, MA.
CervoMed Inc. (CRVO) Historical Performance
IPO Date
CervoMed Inc. (NASDAQ:CRVO) went public on 01 April, 2016.
Change
Since inception, CRVO has decreased by 100.00%. In the last 5 years, CRVO has fallen from $37.50 to $6.91, a massive -81.57% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $97.50 and a low of $2.24.
52 Week Range
$1.8
$26.38
The current price $6.91 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
CRVO Stock Price History
Based on CRVO stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the CRVO stock has fallen from $24.0 - $97.5 to $2.24 - $6.91, which is down -97.29%. Currently, the stock follows downward trend.
Here, we have calculated stock range of CRVO, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $24.0 - $97.5 | $58.06 | -58.58 | 1 Year Change |
| 2021 | $23.25 - $86.25 | $51.06 | -63.57 | 2 Year Change |
| 2022 | $7.2 - $20.25 | $11.68 | -91.67 | 3 Year Change |
| 2023 | $3.0 - $9.87 | $6.64 | -95.26 | 4 Year Change |
| 2024 | $2.34 - $24.29 | $14.89 | -89.38 | 5 Year Change |
| 2025 | $2.24 - $6.91 | $3.8 | -97.29 | 6 Year Change |
CRVO Price Performance
6-Month Performance
CRVO stock dropped by 49.38% in the last six months.
1-Year Performance
The stock has trended downwards by 71.55% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 25.46%.
5-Year Performance
In the last 5 years, the stock has gone down by 81.57%.
According to CervoMed Inc.'s historical data, below graph gives us the exact picture of how the CRVO stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 2 years and a decline in 3 years.
2020
73.91% ↑
2021
61.25% ↓
2022
67.35% ↓
2023
0.53% ↑
2024
69.33% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
CervoMed Inc. (CRVO) Financials & Stock Analysis
Market Capitalization
CervoMed Inc. has a market capitalization of $56.95M, which places CRVO in the micro-cap category.
Fundamental Analysis
EPS: $-0.55 (Q3), $-0.82 (1Y)
EPS increased 103.70% since last quarter, and decreased 92.68% since last year.
Net Income: $-4.75 M (Q3), $-2.17 M (1Y)
Net Income increased 105.17% since last quarter, and decreased 62.57% since last year.
Free Cash Flow: $-4.85 M (Q3), $-7.45 M (1Y)
Free Cash Flow increased N/A since last quarter, and increased 189.57% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for CRVO stock. These indicators help you understand CervoMed Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for CRVO stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $2.66 |
| SMA50 | $2.40 |
| SMA200 | $10.95 |
| RSI | 94.61 |
| Beta |
SMA20 < Current Price
This signals CRVO stock is in short-term bullish momentum.
SMA50 < Current Price
This signals CRVO stock is in mid-term bullish momentum.
SMA200 > Current Price
This signals CRVO stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for CRVO stock is Bearish. Out of all indicators, 3 indicates bullish signals, 5 signals bearish trends and 1 gives neutral trends. The CRVO stock forecast was last updated on 13 March, 2025.
CervoMed Inc. (CRVO) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $9.37 by the end of 2025, and can reach around $25.51 to $8.96 in 2026. And, the long-term forecast suggests that the stock may further jump to $19.91 - $66.35 in 2028, and $21.42 - $15.40 by 2031. So, the CRVO stock shows a strong upward trend in the next several years.
Short-term CRVO Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-04 | $34.59 | 400.58% |
| 2025-05 | $27.73 | 301.3% |
| 2025-06 | $24.69 | 257.31% |
| 2025-07 | $19.53 | 182.63% |
| 2025-08 | $24.29 | 251.52% |
| 2025-09 | $19.81 | 186.69% |
| 2025-10 | $15.85 | 129.38% |
| 2025-11 | $14.10 | 104.05% |
| 2025-12 | $9.37 | 35.6% |
In 2025, the CRVO stock price is expected to fluctuate between $9.37 and $34.59. According to the monthly forecast, the stock could rise to $9.37 by December 2024. If compared to the CRVO's current price, the stock could gain 35.6% by the end of this year.
Long-term CRVO Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $25.51 | $1.40 | $8.96 | 29.67% |
| 2027 | $6.24 | $7.29 | $15.61 | 125.9% |
| 2028 | $19.91 | $17.16 | $66.35 | 860.2% |
| 2029 | $31.72 | $52.66 | $56.80 | 722.0% |
| 2030 | $-2.29 | $24.68 | $28.39 | 310.85% |
| 2031 | $21.42 | $10.55 | $15.40 | 122.87% |
| 2032 | $56.61 | $34.13 | $90.82 | 1214.33% |
| 2033 | $101.08 | $44.03 | $-1.07 | -115.48% |
| 2034 | $6.58 | $47.37 | $112.37 | 1526.19% |
| 2035 | $13.17 | $24.62 | $55.31 | 700.43% |
| 2036 | $123.17 | $33.19 | $41.64 | 502.6% |
| 2037 | $89.77 | $94.38 | $-22.47 | -425.18% |
| 2038 | $34.08 | $49.13 | $23.48 | 239.8% |
| 2039 | $84.52 | $18.27 | $53.14 | 669.03% |
| 2040 | $130.79 | $24.84 | $70.22 | 916.21% |
| 2041 | $55.27 | $138.72 | $10.20 | 47.61% |
| 2042 | $2.46 | $214.68 | $21.33 | 208.68% |
| 2043 | $118.23 | $26.91 | $141.71 | 1950.8% |
| 2044 | $31.06 | $86.22 | $185.14 | 2579.31% |
| 2045 | $77.54 | $99.40 | $36.57 | 429.23% |
| 2046 | $9.94 | $54.63 | $244.96 | 3445.01% |
| 2047 | $83.18 | $110.47 | $45.55 | 559.19% |
| 2048 | $219.83 | $81.32 | $63.84 | 823.88% |
| 2049 | $125.65 | $24.95 | $81.26 | 1075.98% |
| 2050 | $131.30 | $8.49 | $64.26 | 829.96% |
| 2051 | $101.51 | $87.55 | $169.08 | 2346.89% |
CervoMed Inc. (CRVO) Stock Price Prediction & Forecast 2025
At the start of 2025, the CRVO stock was at $2.26. Today, it is trading at $6.91, which is 205.75% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $9.37 by December 2025 with a 35.60% change.
CervoMed Inc. (CRVO) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the CRVO stock. During this period, the CRVO's price is forecasted to shift from $25.51 to $28.39, which is 11.29% gain.
In 2026, the stock would possibly open at $25.51, descends to $1.40 by mid-year, and wraps up at $8.96, reflecting a 29.74% increase from today's price. Further moving to 2030, the stock can kick off the year at $-2.29, drop to $24.68 by mid-year, and finish at $28.39, which is 310.91% change from current price.
CervoMed Inc. (CRVO) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $21.42 to $70.22, which is up 122.85%
In 2031, we can expect CRVO to fluctuate between $15.40 and $21.42, a shift indicating a 122.85% gain by year-end compared to current price. And Until 2040, CRVO can likely vary from $70.22 to $130.79. By the end of 2040, the stock could record a 916.19% rise from today's stock price.
CervoMed Inc. (CRVO) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the CRVO stock can see an an upturn from $55.27 to $64.26 in this period. In 2041, the stock can experience a high of $138.72 by mid-year, closing the year at $10.20. This results in a 1907.59% increase from today.
Moving towards the end of 2050, CRVO is projected to open the year at $131.30. The stock may dip to $8.49 during mid-year and finish the year at $64.26. Compared to the stock's current price, this translates to an overall gain of 830.00% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
CRVO Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals, Inc. | - | $0.14 | -4.90% ▼ | $3861.03 ▲ |
| ARVN | Arvinas, Inc. | - | $8.30 | -53.11% ▼ | $409.53 ▲ |
| TNYA | Tenaya Therapeutics, Inc. | - | $0.46 | -54.95% ▼ | $790.53 ▲ |
| MRSN | Mersana Therapeutics, Inc. | - | $0.54 | 4.07% ▲ | $519.39 ▲ |
| XERS | Xeris Biopharma Holdings, Inc. | - | $4.13 | 7.83% ▲ | $41.7 ▲ |
Last updated Mar 13 at 2:26 PM
CRVO : Buy, Sell Or Hold?
Analyst Ratings
Based on 5 analysts, 0 rated as a strong buy, 4 recommended a buy, 1 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 8 analysts, 1 analysts gave a strong buy rating, 1 a buy rating, 5 a hold rating, 1 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for CRVO stock is Buy.
Expert Analysis
According to CRVO short-term and long-term forecast, CervoMed Inc. shares are projected to go up by 829.96%, and reach a value of $64.26 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 21.428571428571427, which signals Fear. Also, CRVO has recorded 12/30 green days, which reflects a 54.54545454545454% positivity rate with a price volatility of 0.30%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that CRVO stock is undervalued. So, Based on CRVO prediction and analysis, it may be the best time to hold CRVO stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "CRVO” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.